Clinical Trial Update: Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia [Phase 2]

View source ↗

Summary

A Phase 2 trial of nanocrystalline Megestrol plus an immunochemotherapy regimen as first-line therapy for cachexia in extensive-stage small cell lung cancer; th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Immunochemo
• Nanocrystalline Megestrol (Megestrol acetate)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: SCLC, Extensive Stage | Phase 2 | Status: NOT_YET_RECRUITING